T. Rowe Price Associates’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
PI
PCM
LTI
RA
CWM
T. Rowe Price Associates's BSX.PRA Position: Q4 2020 in Review
T. Rowe Price Associates sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q4 2020, closing a stake of 1,914,919 shares — an estimated $214M sold.
T. Rowe Price Associates first reported a position in BSX.PRA in Q2 2020 and held it in 2 quarters. The position peaked at $214M in Q3 2020. 7 funds tracked by Wall St. Rank hold BSX.PRA as of Q4 2020.
- T. Rowe Price Associates reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q4 2020 after selling out during the quarter.
- T. Rowe Price Associates sold 1,914,919 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q4 2020, an estimated $214M.
- T. Rowe Price Associates first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 2 quarters.
- T. Rowe Price Associates's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $214M in Q3 2020.
- 7 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q4 2020.
Based on T. Rowe Price Associates's 13F filing for Q4 2020, filed 16 Feb 2021.